Literature DB >> 28045614

Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus Illusion.

Phuoc T Tran1, Emmanuel S Antonarakis1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28045614      PMCID： PMC5455151          DOI： 10.1200/JOP.2016.018846

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  16 in total

Review 1.  Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer.

Authors:  Jessica M Clement; Christopher J Sweeney
Journal:  J Oncol Pract       Date:  2017-01-03       Impact factor: 3.840

2.  Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.

Authors:  M S Soloway; S W Hardeman; D Hickey; J Raymond; B Todd; S Soloway; M Moinuddin
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

Review 3.  The oligometastatic state - separating truth from wishful thinking.

Authors:  David A Palma; Joseph K Salama; Simon S Lo; Suresh Senan; Tom Treasure; Ramaswamy Govindan; Ralph Weichselbaum
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

Review 4.  Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.

Authors:  Jeffrey J Tosoian; Michael A Gorin; Ashley E Ross; Kenneth J Pienta; Phuoc T Tran; Edward M Schaeffer
Journal:  Nat Rev Urol       Date:  2016-10-11       Impact factor: 14.432

Review 5.  Clinical implications of cancer self-seeding.

Authors:  Elizabeth Comen; Larry Norton; Joan Massagué
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

6.  Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial.

Authors:  Swetha Sridharan; Allison Steigler; Nigel A Spry; David Joseph; David S Lamb; John H Matthews; Chris Atkinson; Keen-Hun Tai; Gillian Duchesne; David Christie; John Attia; Elizabeth G Holliday; James W Denham
Journal:  Radiother Oncol       Date:  2016-08-12       Impact factor: 6.280

Review 7.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

8.  Tumor self-seeding by circulating cancer cells.

Authors:  Mi-Young Kim; Thordur Oskarsson; Swarnali Acharyya; Don X Nguyen; Xiang H-F Zhang; Larry Norton; Joan Massagué
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

9.  The evolutionary history of lethal metastatic prostate cancer.

Authors:  Christopher Foster; Douglas Easton; Ultan McDermott; David C Wedge; G Steven Bova; Gunes Gundem; Peter Van Loo; Barbara Kremeyer; Ludmil B Alexandrov; Jose M C Tubio; Elli Papaemmanuil; Daniel S Brewer; Heini M L Kallio; Gunilla Högnäs; Matti Annala; Kati Kivinummi; Victoria Goody; Calli Latimer; Sarah O'Meara; Kevin J Dawson; William Isaacs; Michael R Emmert-Buck; Matti Nykter; Zsofia Kote-Jarai; Hayley C Whitaker; David E Neal; Colin S Cooper; Rosalind A Eeles; Tapio Visakorpi; Peter J Campbell
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

10.  Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Authors:  Daniel R Gomez; George R Blumenschein; J Jack Lee; Mike Hernandez; Rong Ye; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Chad Tang; Ritsuko Komaki; Alexander V Louie; David A Palma; Anne S Tsao; Boris Sepesi; William N William; Jianjun Zhang; Qiuling Shi; Xin Shelley Wang; Stephen G Swisher; John V Heymach
Journal:  Lancet Oncol       Date:  2016-10-24       Impact factor: 41.316
View more
  3 in total

1.  Developments in oligometastatic hormone-sensitive prostate cancer.

Authors:  Phuoc T Tran; Piet Ost
Journal:  World J Urol       Date:  2019-12       Impact factor: 4.226

2.  Two cases of oligometastatic castration-resistant prostate cancer detected by diffusion-weighted whole-body imaging with background body signal suppression.

Authors:  Yuki Shimizu; Nobuyuki Nakajima; Kentaro Nagao; Masahiro Nitta; Masanori Hasegawa; Yoshiaki Kawamura; Toshiki Kazama; Sunao Shoji; Taro Takahara; Akira Miyajima
Journal:  IJU Case Rep       Date:  2020-02-17

3.  STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer.

Authors:  Ryan M Phillips; Jonathan Hayman; Phuoc T Tran
Journal:  J Clin Oncol       Date:  2017-12-14       Impact factor: 50.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.